SomnusNooze

Announcing Our Updated Research Studies Web Page!

July 17, 2018 in Current Actions, HF Announcements, Research, Take Action!

We’re pleased to announce that we have updated our Research Studies web page (formerly titled Clinical Trials). By CLICKING HERE, you can see our latest information on ongoing research studies about idiopathic hypersomnia (IH) Clinical Trialsand related disorders, results from past research studies (in which you may have participated!), and FAQs about participating in clinical trials.

At our recent conference, several exciting new clinical trials were announced. Get the details about Balance Therapeutics’ new phase 2 trial of BTD-001 for the treatment of IH, Jazz Pharmaceutical’s new trial of low-salt Xyrem for the treatment of IH and narcolepsy, and more. Check out our Research Studies page now (and check back regularly) to see how your participation in clinical trials and other research studies can make a difference in unlocking the mysteries of IH.

We couldn’t do this work without the generous support of our donors like you! Thank you!

Share Post

< SomnusNooze Home Page

SomnusNooze Home Page

SomnusNooze Editions/Archives
Disclaimer

The contents of this website, including text, graphics and other material, are for informational purposes only. This website is not intended to be a substitute for professional legal or medical advice, diagnosis or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Always consult your own attorney or other legal advisor with any legal questions you may have. The Hypersomnia Foundation does not recommend or endorse any specific tests, physicians, lawyers, legal advisors, products, procedures, opinions or other information referenced on this website. Reliance on any information on this website is solely at your own risk.

The Hypersomnia Foundation makes no representations or warranties about the satisfaction of any government regulations requiring disclosure of information on prescription drug products. In no event shall The Hypersomnia Foundation be liable for any damages (including without limitation incidental and consequential damages) or costs (including without limitation attorney’s fees) based on any claim arising from the use of this website and/or its content.